We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Contents
- Part 1: Definitions
- Example: N-of-1 trial
- Example: Number of hrs slept
- Example: Sleep satisfaction
- Example: Severity of complaints
- Example recap
- Important characteristics of N-of-1 trials
- Methodological enhancement
- Randomization in N-of-1 clinical trials
- Randomized block design (1)
- Randomized block design (2)
- Randomized block design: Complaint severity
- Part 2: The main question
- Drawing casual inferences from single patient data
- How to drawing the casual inferences
- Fundamental problem of causal inference
- Example: Randomization test
- Randomization test: evaluation of the test statistic
- Difference in means dot plot
- P-value for the randomization test
- Classification of designs
- Revisiting the randomized block design
- Randomized alternation designs
- Randomized phase designs
- ABAB design
- Classification according to the replication strategy
- Sequential replication design
- Simultaneous replication design
- Multivariate design
- Computer programs: practicality
- Part 3: Reflections
- Current scientific consensus
- The importance of randomization (1)
- The importance of randomization (2)
- Rebel without a cause: Generalizability (1)
- Rebel without a cause: Generalizability (2)
- Conclusion
- Thank you
- Literature (1)
- Literature (2)
- Literature (3)
- Literature (4)
- Literature (5)
- Literature (6)
Topics Covered
- Definitions and examples of N-of-1 clinical trials
- Randomization and blinding of N-of-1 clinical trials
- Classification of N-of-1 design
- Designing N-of-1 clinical trials to draw casual inference
- Current consensus & the importance of randomization
- Generalizability: problems with N-of-1 clinical trials and RCTs
Links
Series:
Categories:
Talk Citation
Onghena, P. (2016, June 30). Randomization in N-of-1 clinical trials: Is it possible to draw causal inferences from single-patient data? [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 5, 2024, from https://doi.org/10.69645/XLBL1562.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Patrick Onghena has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Randomization in N-of-1 clinical trials: Is it possible to draw causal inferences from single-patient data?
Published on June 30, 2016
43 min
Other Talks in the Series: The Risk of Bias in Randomized Clinical Trials
Transcript
Please wait while the transcript is being prepared...
0:00
Welcome to this presentation.
My name is Patrick Onghena
and together with you,
I want to look
into the question,
whether it is possible
to draw casual inferences
from single-patient data.
The answer will turn out
to involve
the introduction
of randomization
in N-of-1 clinical trials.
0:21
So we'll kick off
this presentation
by defining our terms.
What is an N-of-1 clinical
trial?
And what do we mean
by randomization
in N-of-1 clinical trials?
After setting the scene,
we are ready to answer
our main question,
demonstrate how we can
achieve casual inference,
how designs can be classified,
and how the computations
can be made feasible.
We close this presentation
with the discussion
and general reflection
on the current
scientific consensus
about N-of-1 clinical trials
and on the issue
of generalizability.
0:59
N-of-1 clinical trial is defined
as a clinical trial
in which only one single
patient participates.
The purpose of such a trial
is to examine
the relation between one
or more treatments on one hand,
and one or more health related
outcome variables
on the other hand
for that particular patient.
This examination is carried out
by repeatedly introducing
and withdrawing the treatment
and conducting
repeated measurements
for the outcome variable
or variables of interest.
So the N-of-1 part of the term,
refers to the number of patients
involved,
not to the number
of observations,
which has to be much larger
as implied by the definition.
N-of-1 clinical trials are used
in evidence-based medicine,
if the intention is to focus
on a single patient
or if a large-scale
clinical trial
is difficult or impossible,
for example, for rare diseases,
patients with diverse
comorbid conditions
or patients
using concurrent therapies.
Also, financial
and other practical restrictions
may lead the researcher
to opt for N-of-1 clinical trial
or small series
of N-of-1 clinical trials.
For a practitioner
an N-of-1 clinical trial
may also be
the only tool available,
if no large group trial
has been conducted yet
for a specific constellation
of patient symptom
and setting specific
characteristics and nonetheless,
immediate evidence-based
decision and action are needed.
Hide